Dr. Veeral Sheth, MD
Claim this profileUniversity Retina and Macula Associates
Studies Age-Related Macular Degeneration
Studies Macular Degeneration
5 reported clinical trials
9 drugs studied
Affiliated Hospitals
Clinical Trials Veeral Sheth, MD is currently running
4D-150
for Age-Related Macular Degeneration
Phase 1/2 dose-escalation and randomized, controlled, masked expansion trial in adults with wet AMD undergoing active anti-VEGF treatment. Substudies will evaluate the safety and tolerability of 4D-150 contralateral eye dosing and characterize vector shedding.
Recruiting1 award Phase 1 & 23 criteria
OLX10212
for Age-Related Macular Degeneration
This is a Phase 1, multicenter, open-label, single- and multi-dose, dose-escalating study of OLX10212 in patients with neovascular age-related macular degeneration (AMD). This study is composed of 2 parts: Part A and Part B. Part A is a single ascending dose study, and Part B is a multiple ascending dose study. The primary objective is to evaluate the safety and tolerability of single and multiple intravitreal injection(s) of OLX10212 in patients with neovascular AMD. The exploratory objectives are to evaluate the preliminary efficacy of single and multiple intravitreal injection(s) of OLX10212 in patients with neovascular AMD, and to evaluate the pharmacokinetics (PK) of single and multiple intravitreal injection(s) of OLX10212 in patients with neovascular AMD.
Recruiting1 award Phase 1
More about Veeral Sheth, MD
Clinical Trial Related3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Veeral Sheth, MD has experience with
- Faricimab
- Faricimab Injection
- OLX10212
- I-Lumen(TM) AMD
- I-Lumen(TM) AMD Sham
- AVD-104
Breakdown of trials Veeral Sheth, MD has run
Age-Related Macular Degeneration
Macular Degeneration
Diabetic Macular Edema
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Veeral Sheth, MD specialize in?
Veeral Sheth, MD focuses on Age-Related Macular Degeneration and Macular Degeneration. In particular, much of their work with Age-Related Macular Degeneration has involved treating patients, or patients who are undergoing treatment.
Is Veeral Sheth, MD currently recruiting for clinical trials?
Yes, Veeral Sheth, MD is currently recruiting for 2 clinical trials in Oak Forest Illinois. If you're interested in participating, you should apply.
Are there any treatments that Veeral Sheth, MD has studied deeply?
Yes, Veeral Sheth, MD has studied treatments such as Faricimab, Faricimab Injection, OLX10212.
What is the best way to schedule an appointment with Veeral Sheth, MD?
Apply for one of the trials that Veeral Sheth, MD is conducting.
What is the office address of Veeral Sheth, MD?
The office of Veeral Sheth, MD is located at: University Retina and Macula Associates, Oak Forest, Illinois 60452 United States. This is the address for their practice at the University Retina and Macula Associates.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.